Timing of Abatacept Before Elective Arthroplasty and Risk of Postoperative Outcomes.

Compared to continuing intravenous abatacept, withholding abatacept for ≥4 weeks (one dosing interval) before surgery was not associated with a lower risk of hospitalized infection, nonurinary hospitalized infection, PJI, or 30-day readmission.